Eric Kelsic

Eric Kelsic, CEO and co-founder of Dyno Therapeutics, shares his journey from a physics and systems biology background to revolutionizing gene therapy. He discusses insights from working with George Church, emphasizing the importance of innovation. Kelsic unveils Dyno's AI-driven capsid engineering for AAV gene therapy, spotlighting collaborations and resource leverage for startup success. With a vision for transforming treatment access, he highlights the role of machine learning in addressing real-world health challenges.

Eric Kelsic, CEO of Dyno Therapeutics and expert in AI-driven protein engineering, dives into the challenge of gene therapy delivery. He discusses the revolutionary concept of genetic agency, empowering patients to act at the DNA level. Discover how improved delivery methods could potentially allow treatments for most genetic diseases and extend healthy lives. Kelsic explains how AI is reshaping capid design to enhance safety and effectiveness, all while sharing insights on upcoming conferences focused on genetic medicine's future.